Last update:

Weight management news

Bariatric surgery is effective rescue strategy after GLP-1 receptor agonist failure

Bariatric surgery is associated with clinically meaningful two-year weight loss after semaglutide or tirzepatide intolerance or inadequate response, according to a study published online Nov. 3 in the Annals of Surgery.

Obesity drugs could lead to new ways to protect the brain

Drugs such as semaglutide and tirzepatide are already used to treat obesity and type 2 diabetes, but they also influence biological processes important for brain function. In a new review published in Science, researchers ...

Are GLP-1s practical and safe for adolescents with obesity?

GLP-1 medications have become a popular tool for weight loss. But are they appropriate for all age groups? Short for glucagon-like peptide-1, GLP-1s are medications approved by the Food and Drug Administration that treat ...